Trials / Completed
CompletedNCT07008313
Enhanced Recovery After Surgery Promotes the Rehabilitation of Patients With Acute Gastrointestinal Perforation in Perioperative Period
Enhanced Recovery After Surgery Promotes the Rehabilitation of Patients With Acute Gastrointestinal Perforation, a Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 362 (actual)
- Sponsor
- Hebei Medical University · Academic / Other
- Sex
- All
- Age
- 14 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The enhanced recovery after surgery(ERAS) has been gradually extended from its initial colorectal surgery to almost all surgical fields. However, there are few reports about the application value of ERAS in emergency surgery. The goal of this clinical trial is to evaluate the value of ERAS in the perioperative period of acute gastrointestinal perforation. All the patients will be treated by emergency operation. The changes of CRP, PA, PCT in Plasma 1 hour before operation and 1,3,7 days after operation, the operation time, the amount of bleeding during operation, the recovery time of intestinal function and the time of the first meal after operation,the incidence of postoperative complications, the degree of postoperative pain, the time of first out-of-bed activity, fatigue and mental status, quality of life, the length and the cost of hospital stay will be monitored and recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | The enhanced recovery after surgery | Enhanced recovery after surgery (ERAS) refers to a series of optimal management measures which are proved to be effective by evidence-based medical evidence in order to reduce patients' psychological and physiological traumatic stress reaction |
| BEHAVIORAL | Traditional treatment methods. | Traditional treatment methods. |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2023-01-01
- Completion
- 2023-01-31
- First posted
- 2025-06-06
- Last updated
- 2025-06-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07008313. Inclusion in this directory is not an endorsement.